Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary TuberculosisWilliam J. Burman, Richard E. Chaisson, Zhen Zhao et al.|American Journal of Respiratory and Critical Care Medicine|2006Cited by 285
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-AnalysisDick Menzies, William J. Burman, Madhukar Pai et al.|PLoS Medicine|2009Cited by 225
Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysisDick Menzies, Christian Lienhardt, Madhukar Pai et al.|PLoS Medicine|2009Cited by 196
Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and RifapentineMarc Weiner, Thomas Hodge, Charles A. Peloquin et al.|American Journal of Respiratory and Critical Care Medicine|2003Cited by 193
Effects of Tuberculosis, Race, and Human Gene <i>SLCO1B1</i> Polymorphisms on Rifampin ConcentrationsMarc Weiner, Andrew Vernon, Erin Bliven-Sizemore et al.|Antimicrobial Agents and Chemotherapy|2010Cited by 156